The lithium ion: A foundation for psychopharmacological specificity

Neuropsychopharmacology

Volumn 19, Issue 3, 1998, Pages 167-182

  Soares, Jair C ^a   Gershon, Samuel ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Bipolar disorder; Lithium; Psychopharmacology; Specificity; Therapeutics

Indexed keywords

LITHIUM; LITHIUM ION;

BIPOLAR DEPRESSION; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SPECIFICITY; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW;

EID: 0032171402     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00022-0     Document Type: Article

References (230)

1. Abe K. Lithium prophylaxis of periodic hypersomnia. Brit J Psychiat. 130:1977;312-316.
2. Abou-Saleh M.T. Platelet MAO. Personality and response to lithium prophylaxis J Aff Dis. 5:1983;55-65.
3. Abou-Saleh M.T., Coppen A. Who responds to prophylactic lithium? J Aff Dis. 10:1986;115-125.
4. Abrams T., Taylor M.A. Mania and schizo-affective disorder, manic type. A comparison Am J Psychiat. 133:1976;1445-1447.
5. Albright P.S., Burnham W.M. Development of a new pharmacological seizure model. Effects of anticonvulsants on cortical and amygdala-kindled seizures in the rat Epilepsia. 21:1980;681-689.
6. Alexander P.E., van Kammen D.P., Bunney W.E. Jr. Antipsychotic effects of lithium in schizophrenia. Am J Psychiat. 136:1979;283-287.
7. Altshuler K.Z., Abdullah S., Rainer J.D. Lithium and aggressive behavior in patients with early total deafness. Dis Nerv Syst. 38:1977;521-524.
8. Antelman S.M., Caggiula A.R., Kiss S., Edwards D.J., Kocan D., Stiller R. Neurochemical and physiological effects of cocaine oscillate with sequential drug treatment. Possibly a major factor in drug variability Neuropsychopharmacology. 12:1995;297-306.
9. + in the treatment of bipolar disorder. Trend Neurosci. 18:1995;343-349.
10. Atre-Vaidya N., Taylor M.A. Effectiveness of lithium in schizophrenia. Do we really have an answer? J Clin Psychiat. 50:1989;170-173.
11. Baastrup P.C. The use of lithium in manic depressive psychosis. Comp Psychiat. 5:1964;396-408.
12. Baastrup P.C., Schou M. Lithium as a prophylactic agent. Arch Gen Psychiat. 16:1967;162-172.
13. Baastrup P.C., Poulsen J.C., Schou M., Thomsen K., Amdisen A. Prophylactic lithium. Double-blind discontinuation in manic-depressive and recurrent-depressive disorders Lancet. 2:1970;326-330.
14. Ballenger J.C. The use of anticonvulsants in manic-depressive illness. J Clin Psychiat. 49:1988;21-25.
15. Ballenger J.C., Post R.M. Carbamazepine in manic-depressive illness. A new treatment Am J Psychiat. 137(7):1980;782-790.
16. Baraban J.M., Worley P.F., Snyder S.H. Second messenger systems and psychoactive drug action. Focus on the phosphoinositide system and lithium Am J Psychiat. 146:1989;1251-1260.
17. Baron M., Gershon E.S., Rudy V., Jonas W.Z., Buchsbaum M. Lithium carbonate response in depression. Prediction by unipolar-bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiat. 32:1975;1107-1111.
18. Black D.W., Winokur G., Nasrallah A. Treatment of mania. A naturalistic study of electroconvulsive therapy versus lithium in 438 patients J Clin Psychiat. 48:1987;132-139.
19. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., Garza-Trevino E.S., Risch S.C., Goodnick P.J., Morris D.D. Efficacy of divalproex vs. lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 271:1994;918-924.
20. Bowden C.L. Predictors of response to divalproex and lithium. J Clin Psychiat. 56:1995;25-30.
21. Braden W. Response to lithium in a case of L-dopa-induced psychosis. Am J Psychiat. 134:1977;808-809.
22. Braden W., Fink E.B., Qualls C.B., Ho C.K., Samuels W.O. Lithium and chlorpromazine in psychotic inpatients. Psychiat Res. 7:1982;69-81.
23. Brockington I.F., Kendell R.E., Kellett J.M., Curry S.H., Wainwright S. Trials of lithium, chlorpromazine, and amitriptyline in schizoaffective patients. Brit J Psychiat. 133:1978;162-168.
24. Brockington I.F., Wainwright S., Kendell R.E. Manic patients with schizophrenic or paranoid symptoms. Psycholog Med. 10:1980;73-83.
25. Cade J.F.J. Lithium salts in the treatment of psychotic excitement. Med J Australia. 14:1949;349-352.
26. Calabrese J.R., Delucchi G.A. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiat. 147:1990;431-434.
27. Calabrese J.R., Markovitz P.J., Kimmel S.E., Wagner S.C. Spectrum of efficacy of valproate in 78 rapid-cycling bipolar patients. J Clin Psychopharmacol. 12:1992;53-56.
28. Campbell M., Adams P.B., Small A.M., Kafantaris V., Silva R.R., Shell J., Perry R., Overall J.E. Lithium in hospitalized aggressive children with conduct disorder. A double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiat. 34:1995;445-453. a.
29. Carpenter W.T., Kurz R., Kirkpatrick B., Hanlon T.E., Summerfelt T., Buchanan R.W., Waltrip R.W., Breier A. Carbamazepine maintenance treatment in outpatient schizophrenics. Arch Gen Psychiat. 48:1991;69-72.
30. Clothier J., Swann A.C., Freeman T. Dysphoric mania. J Clin Psychopharmacol. 12:1992;13S-16S.
31. Coppen A., Noguera R., Bailey J., Burns B.H., Swani M.S., Hare E.H., Gardner R., Maggs R. Prophylactic lithium in affective disorders - Controlled trial. Lancet, August. 275-279:1971.
32. Coryell W., Endicott J., Maser J.D., Mueller T., Lavori P., Keller M. The likelihood of recurrence in bipolar affective disorder. The importance of episode recency J Aff Dis. 33:1995;201-206.
33. Coxhead N., Silverstone T., Cookson J. Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder. Acta Psychiat Scand. 85:1992;114-118.
34. Craft M., Ismail I.A., Krishnamurti D., Mathews J., Regan A., Seth R.V., North P.M. Lithium in the treatment of aggression in mentally handicapped patients. A double-blind trial. Brit J Psychiat. 150:1987;685-689.
35. Cronson A.J., Flemenbaum A. Antagonism of cocaine highs by lithium. Am J Psychiat. 135:1978;856-857.
36. Crow T.J. Continuum of psychoses and its genetic origins. The Sixty-Fifth Maudsley Lecture. Brit J Psychiat. 150:1990;788-797.
37. Cundall R.L., Brooks P.W., Murray L.G. A controlled evaluation of lithium prophylaxis in affective disorders. Psycholog Med. 2:1972;308-311.
38. Dardennes R., Even C., Bange F., Heim A. Comparison of carbamazepine and lithium in the prophylaxis of bipolar disorders - A meta-analysis. Brit J Psychiat. 166:1995;378-381.
39. DeLong G.R. Lithium carbonate treatment of select behavior disorders in children suggesting manic-depressive illness. J Pediat. 93:1978;689-694.
40. DeLong G.R., Nieman G.W. Lithium-induced behavioral changes in children with symptoms suggesting manic-depressive illness. Psychopharmacol Bull. 19:1983;258-265.
41. Delve N.J., Letemendia F.J.J. Lithium treatment in schizophrenia and schizo-affective disorders. Brit J Psychiat. 141:1982;387-400.
42. de Montigny C. Lithium addition in treatment-resistant depression. Int Clin Psychopharmacol. 9:1994;31-35.
43. DePetrillo P.B., Abernethy D.R., Wainer I.W., Andrawis N.S. Verapamil decreases lymphocyte protein kinase C activity in humans. Clin Pharmacol Therapeu. 55:1994;44-49.
44. Dickson W.E., Kendell R.E. Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psycholog Med. 16:1986;521-530.
45. Di Constanzo E., Schifano F. Lithium alone or in combination with carbamazepine for the treatment of rapid-cycling bipolar affective disorder. Acta Psychiat Scand. 83:1991;456-459.
46. Dilsaver S.C., Swann A.C., Shoaib A.M., Bowers T.C., Halle M.T. Depressive mania associated with response to antimanic agent. Am J Psychiat. 150:1993;1548-1551.
47. Dinsmore P.R., Ryback R. Lithium in schizo-affective disorders. Dis Nerv Syst December. 771-776:1972.
48. Dorus W., Ostrow D.G., Anton R., Cushman P., Collins J.F., Schaefer M., Charles H.L., Desai P., Hayashida M., Malkerneker U., Willenbring M., Fiscella R., Sather M.R. Lithium treatment of depressed and nondepressed alcoholics. JAMA. 262:1989;1646-1652.
49. Dostal T., Zvolsky P. Antiaggressive effect of lithium salts in severe mentally retarded adolescents. Int Pharmacopsychiat. 5:1970;203-207.
50. Dubovsky S.L., Christiano J., Daniell L.C., Franks R.D., Murphy J., Adler L., Baker N., Harris A. Increased platelet intracellular calcium concentration in patients with bipolar affective disorder. Arch Gen Psychiat. 46:1989;632-638.
51. Dubovsky S.L., Lee C., Christiano J., Murphy J. Elevated platelet intracellular calcium concentration in bipolar depression. Biolog Psychiat. 29:1991;441-450.
52. Dubovsky S.L., Murphy J., Thomas M., Rademacher J. Abnormal intracellular calcium ion concentration in platelets and lymphocytes of bipolar patients. Am J Psychiat. 149:1992;118-120.
53. Dubovsky S.L., Thomas M., Hijazi A., Murphy J. Intracellular calcium signalling in peripheral cells of patients with bipolar affective disorder. Eur Arch Psychiat Clin Neurosci. 243:1994;229-234.
54. Dunner D.L., Stallone F., Fieve R.R. Lithium carbonate and affective disorders. V. A double-blind study of prophylaxis of depression in bipolar illness Arch Gen Psychiat. 33:1976;117-120.
55. Ebert D., Jaspert A., Murata H., Kaschka W.P. Initial lithium augmentation improves the antidepressant effects of standard TCA treatment in nonresistant depressed patients. Psychopharmacology. 118:1995;223-225.
56. Elphick M. An open trial of carbamazepine in treatment-resistant bipolar and schizo-affective psychotics. Brit J Psychiat. 147:1985;198-200.
57. Emrich H.M., Dose M., von Zerssen D. The use of sodium valproate, carbamazepine, and oxcarbazepine in patients with affective disorders. J Aff Dis. 8:1985;243-250.
58. Faedda G.L., Baldessarini R.J., Tohen N., Strakowski S.M., Waternaux C. Episode sequence in bipolar disorder and response to lithium treatment. Am J Psychiat. 148:1991;1237-1239.
59. Fava M., Rosenbaum J.F., McGrath P.J., Stewart J.W., Amsterdam J.D., Quitkin F.M. Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression. A double-blind, controlled study Am J Psychiat. 155:1994;1372-1374.
60. Fawcett J., Clark D.C., Aagesen C.A., Pisani V.D., Tilkin J.M., Sellers D., McGuire M., Gibbons R.D. A double-blind, placebo-controlled trial of lithium carbonate therapy for alcoholism. Arch Gen Psychiat. 44:1987;248-256.
61. Fieve R.R., Dunner D.L., Kumbarachi T., Stallone F. Lithium carbonate in affective disorders. IV. A double-blind study of prophylaxis unipolar recurrent depression. Arch Gen Psychiat. 32:1975;1541-1544.
62. Fieve R.R., Dunner D.L., Kumbaraci T., Stallone F. Lithium carbonate prophylaxis of depression in three subtypes in primary affective disorder. Pharmakopsychiat Neuro-Psychopharmakol. 9:1976;100-107.
63. Folks D.G., King L.D., Dowdy S.B., Petrie W.M., Jack R.A., Kooman J.C., Swenson B.R., Edwards P. Carbamazepine treatment of affectively disordered inpatients. Am J Psychiat. 139(1):1982;115-117.
64. Freeman T.W., Clothier J.L., Passaglia P., Lesem M.D., Swann A.C. A double-blind comparison of valproate and lithium in the treatment of acute mania. Am J Psychiat. 149:1992;108-111.
65. Fogelson D.L., Jacobson S., Sternbach H. A retrospective study of valproate in private psychiatric practice. Ann Clin Psychiat. 3:1991;315-320.
66. 2+ response in neutrophils from patients under chronic lithium therapy. Eur Arch Psychiat Clin Neurosci. 243:1994;240-243.
67. Friedman E., Wang H.Y., Levinson D., Connell T.A., Singh H. Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biolog Psychiat. 33:1993;520-525.
68. Garfinkel P.E., Stancer H.C., Persad E. A comparison of haloperidol, lithium carbonate, and their combination in the treatment of mania. J Aff Dis. 2:1980;279-288.
69. Garver D.L., Hirschowitz J., Fleischman R., Djuric P.E. Lithium response and psychosis. A double-blind placebo-controlled study Psychiat Res. 12(1):1984;S7-S8.
70. Gaviria M., Flaherty J., Val E. A comparison of bipolar patients with and without a borderline personality disorder. Psychiatric J Univ Ottawa. 7:1982;190-195.
71. Geisler A., Schou M. Lithium treatment of obsessive-compulsive neurosis. A double-blind therapeutic trial with negative result Foreign Psychiat. 2:1973;90-94.
72. Gershon S., Trautner E.M. The treatment of shock dependency by pharmacological agents. Med J Australia. 12(7):1956;S2-S12.
73. Gershon S., Yuwiler A. Lithium ion. A specific psychopharmacological approach to the treatment of mania J Neuropsychiat. 1:1960;229-241.
74. Gershon S. Lithium in mania. Clin Pharmacol Therapeu. 11:1970;168-187.
75. Gershon S., Soares J.C. Current therapeutic profile of lithium. Arch Gen Psychiat. 54:1997;16-20.
76. Glen A.I., Johnson A.L., Shepherd M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness. A randomized, double-blind, controlled trial Psycholog Med. 14:1984;37-50.
77. Goetzl U., Gruenberg F., Berkowit B. Lithium carbonate in management of hyperactive aggressive behavior of mentally retarded. Comp Psychiat. 18:1977;599-606.
78. Goodwin F.K., Murphy D.L., Dunner D.L., Bunney W.E. Jr. Lithium response in unipolar versus bipolar depression. Am J Psychiat. 129:1972;44-47.
79. Goodwin F.K., Zis A.P. Lithium in the treatment of mania - Comparisons with neuroleptics. Arch Gen Psychiat. 36:1979;840-844.
80. Goodwin F.K., Jamison K.R. Manic-Depressive Illness. 1990;Oxford University Press, New York.
81. Goodwin G.M. Recurrence of mania after lithium withdrawal - Implications for the use of lithium in the treatment of bipolar affective disorder. Brit J Psychiat. 164:1994;149-152.
82. Goodwin G.M. Lithium revisited - A reply. Brit J Psychiat. 167:1995;573-574.
83. Grof P., Alda M., Grof E., Fox D., Cameron P. The challenge of predicting response to stabilizing lithium treatment. The importance of patient selection. Brit J Psychiat. 21:1993;16-19.
84. Growe G.A., Crayton J.W., Klass D.B., Evans H., Strizich M. Lithium in chronic schizophrenia. Am J Psychiat. 136:1979;454-455.
85. Guscott R., Taylor L. Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness, and efficiency. Brit J Psychiat. 164:1994;741-746.
86. Harrow M., Goldberg J.F., Grossman L.S., Meltzer H.Y. Outcome in manic disorders. A naturalistic follow-up study Arch Gen Psychiat. 47:1990;665-671.
87. Hartigan G.P. The use of lithium salts in affective disorders. Brit J Psychiat. 109:1963;810-814.
88. Hayes S.G. Long-term valproate prophylaxis in refractory affective disorders. Ann Clin Psychiat. 4:1992;55-63.
89. Heninger G.R., Charney D.S., Sternberg D.E. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression. Arch Gen Psychiat. 40:1983;1335-1342.
90. Himmelhoch J.M., Mulla D., Neil J.F., Detre T.P., Kupfer D.J. Incidence and significance of mixed affective states in a bipolar population. Arch Gen Psychiat. 33:1976;1062-1066.
91. Himmelhoch J.M., Thase M.F., Mallinger A.G., Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiat. 148:1991;910-916.
92. Hirschowitz J., Casper R., Garver D.L., Chang S. Lithium response in good prognosis schizophrenia. Am J Psychiat. 137:1980;916-920.
93. Hirschowitz J., Zemlan F.P., Garver D.L. Growth hormone levels and lithium ratios as predictors of success of lithium therapy in schizophrenia. Am J Psychiat. 139:1982;646-649.
94. Horowitz H.A. The use of lithium in the treatment of the drug-induced psychotic reaction. Dis Nerv Syst. 36:1975;159-163.
95. Hullin RP, McDonald R, Allsopp MNE (1972): Prophylactic lithium in recurrent affective disorders. Lancet ii:1044-1046.
96. Jeffries J.J., Lefebvre A. Depression and mania associated with Kleine-Levin-Critchley syndrome. Can Psychiatric Ass J. 18:1973;439-444.
97. Joffe R.T., Singer W., Levitt A.J., MacDonald C. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiat. 50:1993;387-393.
98. Johnson G., Gershon S., Hekimian L.J. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states. An interim report Comp Psychiat. 9:1968;563-573.
99. Johnson G (1970): Differential response to lithium carbonate in manic depressive and schizo-affective disorders. Dis Nerv Syst, September:613-615.
100. Johnson G., Gershon S., Burdock E.I., Floyd A., Hekimian L. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Brit J Psychiat. 119:1971;267-276.
101. Johnson G. Antidepressant effect of lithium. Comp Psychiat. 15:1974;43-47.
102. Judd L.L., Huey L.Y. Lithium antagonizes ethanol intoxication of alcoholics. Am J Psychiat. 141:1984;1517-1521.
103. Kane J.M., Quitkin F.M., Rifkin A., Ramos-Lorenzi J.R., Nayak D.D., Howard A. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness. A prospective, placebo-controlled comparison Arch Gen Psychiat. 39:1982;1065-1069.
104. Keck P.E. Jr., McElroy S.L., Nemeroff C.B. Anticonvulsants in the treatment of bipolar disorder. J Neuropsychiatry Clin Neurosci. 4:1992;395-405.
105. Keller M.B., Lavori P.W., Coryell W., Endicott J., Mueller T.I. Bipolar I. A five-year prospective follow-up J Nervous Mental Dis. 181:1993;238-245.
106. Kendell R.E. The diagnosis of mania. J Aff Dis. 8:1985;207-213.
107. Khan M.C., Wickham E.A., Reed J.V. Lithium versus placebo in acute depression. A clinical trial Int Clin Psychopharmacol. 2:1987;47-54.
108. Kofman O., Belmaker R.H. Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression. Biolog Psychiat. 34:1993;839-852.
109. Krauthammer C., Klerman G.L. Secondary mania - Manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiat. 35:1978;1333-1339.
110. Kutcher S.P., Marton P., Korenblum M. Adolescent bipolar illness and personality disorder. J Am Acad Child Adoles Psychiat. 29:1990;355-358.
111. Lambert P.A., Carraz G., Borselli S., Carrel M.S. Action neuropsychotrope d'un nouvel anti-épileptique. le dépamide Ann M Psychol. 1:1966;707-710.
112. Lambert P.A. Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). Emrich H.M., Okuma T., Muller A.A. Anticonvulsants in Affective Disorders. 1984;33-44 Excerpta Medica, Amsterdam.
113. Lejoyeux M., Ades J. Evaluation of lithium treatment in alcoholism. Alcohol Alcoholism. 28:1993;273-279.
114. Lerer B. Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biolog Psychiat. 20:1985;20-40.
115. Lerer B., Moore N., Meyendorff E., Cho S.R., Gershon S. Carbamazepine versus lithium in mania. A double-blind study J Clin Psychiat. 48:1987;89-93.
116. Linder J., Fyro B., Pettersson U., Werner S. Acute antidepressant effect of lithium is associated with fluctuation of calcium and magnesium in plasma. A double-blind study on the antidepressant effect of lithium and clomipramine. Acta Psychiat Scand. 80:1989;27-36.
117. Lingjaerde O., Edlund A.H., Gormsen C.A., Gottfries C.G., Haugstad A., Hermann I.L., Hollnagel P., Makimattilla A., Rasmussen K.E., Remvig J., Robak O.H. The effects of lithium carbonate in combination with tricyclic antidepressants in endogenous depression. A double-blind, multicenter trial. Acta Psychiat Scand. 50:1974;233-242.
118. Lusznat R.M., Murphy D.P., Nunn C.M. Carbamazepine vs. lithium in the treatment and prophylaxis of mania. Brit J Psychiat. 153:1988;198-204.
119. Maj M. Effectiveness of lithium prophylaxis in schizoaffective psychosis. Application of a polydiagnostic approach Acta Psychiat Scand. 70:1984;228-234.
120. Maj M. Lithium prophylaxis of schizoaffective disorders. A prospective study J Aff Dis. 14:1988;129-135.
121. Maj M., Pirozzi R., Starace F. Previous pattern of course of the illness as a predictor of response to lithium prophylaxis in bipolar patients. J Aff Dis. 17:1989;237-241.
122. Maj M., Pirozzi R., Kemali D. Long-term outcome of lithium prophylaxis in bipolar patients. Arch Gen Psychiat. 48:1991;772.
123. Mander A.J. Is there a lithium withdrawal syndrome? Brit J Psychiat. 149:1986;498-501.
124. Mander A.J., Loudon J.B. Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet. 2:1988;15-17.
125. Manji H.K., Lenox R.H. Long-term action of lithium. A role for transcriptional and postranscriptional factors regulated by protein kinase C Synapse. 16:1994;11-28.
126. Manji H.K., Potter W.Z., Lenox R.H. Signal transduction pathways. Molecular targets for lithium's action. Arch Gen Psychiat. 52:1995;531-543.
127. Marini J.I., Sheard M.H. Antiaggressive effect of lithium ion in man. Acta Psychiat Scand. 55:1977;269-286.
128. Mattsson B., von Schoultz B. A comparison between lithium, placebo, and a diuretic in premenstrual tension. Acta Psychiat Scand. 255:1974;75-84.
129. McCoy L., Votolato N.A., Schwarzkopf S.B., Nasrallah H.A. Clinical correlates of valproate augmentation in refractory bipolar disorder. Ann Clin Psychiat. 5:1993;29-33.
130. McDougle C.J., Price L.H., Goodman W.K., Charney D.S., Heninger G.R. A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder. Lack of efficacy J Clin Psychopharmacol. 11:1991;175-184.
131. McElroy S.L., Keck P.E. Jr., Pope H.G. Jr. Sodium valproate. its use in primary psychiatric disorders J Clin Psychopharmacol. 7:1987;16-24.
132. McElroy S.L., Keck P.E., Pope H.G., Hudson J.I. Valproate in the treatment of rapid cycling bipolar disorder. J Clin Psychopharmacol. 8:1988;275-278.
133. McElroy S.L., Keck P.E. Jr., Pope H.G. Jr., Hudson J.I., Faedda G.L., Swann A.C. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiat. 149:1992;1633-1644. a.
134. McElroy S.L., Keck P.E. Jr., Pope H.G. Jr., Hudson J.I. Valproate in the treatment of bipolar disorder. Literature review and clinical guidelines J Clin Psychopharmacol. 12:1992;42S-52S. b.
135. Mehta D.B. Lithium and affective disorders associated with organic brain impairment. Am J Psychiat. 133:1976;236.
136. Mendels J., Secunda S.K., Dyson W.L. A controlled study of the antidepressant effect of lithium carbonate. Arch Gen Psychiat. 26:1972;154-157.
137. Mendels J. Lithium in the treatment of depression. Am J Psychiat. 133:1979;373-378.
138. Mendlewicz J., Stallone F. Genetic factors and lithium response in manic-depressive illness. Mod Prob Pharmacopsychiat. 10:1975;23-29.
139. Merry J., Reynolds C.M., Bailey J., Coppen A. Prophylactic treatment of alcoholism by lithium carbonate. A controlled study. Lancet. 1:1976;481-482.
140. Miller F.T., Libman H. Lithium carbonate in the treatment of schizophrenia and schizo-affective disorder. Review and hypothesis Biol Psychiat. 14:1979;705-710.
141. Moskowitz I.A. Lithium and lady luck. Use of lithium carbonate in compulsive gambling NY State J Med. 80:1980;785-788.
142. Moncrieff J. Lithium revisited - A re-examination of the placebo-controlled trials of lithium prophylaxis in manic-depressive disorder. Brit J Psychiat. 167:1995;569-574.
143. Naylor G.J., Donald J.M., Le Poidevin D., Reid A.H. A double-blind trial of long-term lithium therapy in mental defectives. Brit J Psychiat. 124:1974;52-57.
144. Neppe V.M. Carbamazepine in nonresponsive psychosis. J Clin Psychiat. 49:1988;22-28.
145. Noack C.H., Trautner E.M. Lithium treatment of maniacal psychosis. Med J Australia. 18:1951;219-222.
146. Noyes R. Jr., Dempsey M., Blum A., Cavanaugh G.L. Lithium treatment of depression. Comp Psychiat. 15:1974;187-193.
147. O'Connell R.A., Mayo J.A., Flatow L.et al. Outcome of bipolar disorder on long-term treatment with lithium. Brit J Psychiat. 159:1991;123-129.
148. Ogura C., Okuma T., Nakazawa K.et al. Treatment of periodic somnolence with lithium carbonate. Arch Neurol. 33:1976;143.
149. Okuma T., Inanaga K., Otsuki S.et al. Comparison of the antimanic efficacy of carbamazepine and chlorpromazine. A double-blind controlled study Psychopharmacology. 66:1979;211-217.
150. Okuma T., Inanaga K., Otsuki S.et al. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology. 73:1981;95-96.
151. Okuma T. Therapeutic and prophylactic effects of carbamazepine in bipolar disorders. Psychiat Clin North Am. 6:1983;157-174.
152. Okuma T., Yamashita I., Takahashi R., Itoh H., Otsuki S., Watanabe S., Sarai K., Hazama H., Inanaga K. Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry. 23:1990;143-150.
153. Perris C. Morbidity suppressive effect of lithium carbonate in cycloid psychosis. Arch Gen Psychiat. 35:1978;328-331.
154. Peselow E.D., Fieve R.R., Difiglia C.et al. Lithium prophylaxis of bipolar illness. Brit J Psychiat. 164:1994;208-214.
155. Petty F. GABA and mood disorders. A brief review and hypothesis J Aff Dis. 34:1995;275-281.
156. Placidi G.F., Lenzi A., Lazzerini F., Cassano G.B., Akiskal H.S. The comparative efficacy and safety of carbamazepine versus lithium. A randomized, double-blind 3-year trial in 83 patients J Clin Psychiat. 47:1986;490-494.
157. Platman S.R. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiat. 127:1970;351-353.
158. Pond S.M., Becker C.E., Vandervoort R., Phillips M., Bowler R.M., Peck C.C. An evaluation of the effects of lithium in the treatment of chronic alcoholism. I. Clinical results. Alcohol Clin Exper Res. 5:1981;247-251.
159. Pope H.G. Jr., Lipinski J.F., Cohen B.M., Axelrod D.T. "Schizoaffective disorder" An invalid diagnosis? A comparison of carbamazepine disorder, schizophrenia, and affective disorder Am J Psychiat. 137:1980;921-927.
160. Post R.M. The use of the anticonvulsant carbamazepine in primary and secondary affective illness. Clinical and theoretical implications Psycholog Med. 12:1982;701-704.
161. Post R.M., Uhde T.W., Ballenger J.C., Squillace K.M. Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiat. 140:1983;1602-1604.
162. Post R.M., Uhde T.W., Roy-Byrne P.P., Joffe R.T. Correlates of antimanic response to carbamazepine. Psychiat Res. 21:1987;71-83.
163. Post R.M., Altshuler L.L., Ketter T.A., Denicoff K., Weiss S.R. Antiepileptic drugs in affective illness. Clinical and theoretical implications. Adv Neurol. 55:1991;239-277.
164. Post R.M., Weiss S.R., Chuang D.M. Mechanisms of action of anticonvulsants in affective disorders. comparisons with lithium J Clin Psychopharmacol. 12:1992;23S-35S.
165. Potter W.Z., Bowden C.L. Valproate and mood disorders. Perspectives. Introduction J Clin Psychopharmacol. 12:1992;2S-6S.
166. Price L.H., Henninger G.R. Lithium in the treatment of mood disorders. N Engl J Med. 331:1994;591-598.
167. Prien R.F., Caffey E.M., Klett C.J. Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiat. 26:1972;146-153. a.
168. Prien R.F., Caffey E.M. Jr., Klett C.J. A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group. Arch Gen Psychiat. 27:1972;182-189. b.
169. Prien R.F., Caffey E.M., Klett C.J. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiat. 28:1973;337-341. a.
170. Prien R.F., Klett J., Caffey E.M. Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiat. 29:1973;420-425. b.
171. Prien R.F., Klett C.J., Caffey E.M. Jr. Lithium prophylaxis in recurrent affective illness. Am J Psychiat. 131:1974;198-203.
172. Prien R.F., Kupfer D.J., Mansky P.A., Small J.G., Tuason V.B., Voss C.B., Johnson W.E. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiat. 41:1984;1096-1104.
173. Prien R.F., Himmelhoch J.M., Kupfer D.J. Treatment of mixed mania. J Aff Dis. 15:1988;9-15. a.
174. Prien R.F. Maintenance treatment of depressive and manic states. Georgotas A., Cancro R. Depression and Mania. 1988;439-451 Elsevier Science, New York. b.
175. Prien R.F., Gelenberg A.J. Alternatives to lithium for preventive treatment of bipolar disorder. Am J Psychiat. 146:1989;840-848.
176. Prien R.F., Potter W.Z. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull. 26:1990;409-427.
177. Puzynski S., Klosiewicz L. Valproic acid amide in the treatment of affective and schizoaffective disorders. J Aff Dis. 6:1984;115-121.
178. Quitkin F.M., Kane J., Rifkin A., Ramos-Lorenzi J.R., Nayak D.V. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. Arch Gen Psychiat. 38:1981;902-907. a.
179. Quitkin F.M., Kane J.M., Rifkin A., Ramos-Lorenzi J.R., Saraf K., Howard A., Klein D. Lithium and imipramine in the prophylaxis of unipolar and bipolar II depression. A prospective, placebo-controlled comparison Psychopharmacol Bull. 17:1981;142-144. b.
180. Ryback R.S., Schwab R.S. Manic response to levodopa therapy. Report of a case N Engl J Med. 825:1971;788-789.
181. Sarantidis D., Waters B. Predictors of lithium prophylaxis effectiveness. Prog Neuropsychopharmacol Biol Psychiat. 5:1981;507-510.
182. Sautter F., Garver D. Familial differences in lithium responsive versus lithium nonresponsive psychoses. J Psychiat Res. 19:1985;1-8.
183. Sautter F.J., McDermott B.E., Garver D.L. A family study of lithium-responsive psychosis. J Aff Dis. 20:1990;63-69.
184. Schexnayder L.W., Hirschowitz J., Sautter F.J., Garver D.L. Predictors of response to lithium in patients with psychoses. Am J Psychiat. 152:1995;1511-1513.
185. Schnur D.B., Mukherjee S., Sackeim H.A., Lee C., Roth S.D. Symptomatic predictors of ECT response in medication-nonresponsive manic patients. J Clin Psychiat. 53:1992;63-66.
186. Schopf J., Baumann P., Lemarchand T., Rey M. Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study. Pharmacopsychiatry. 22:1989;183-187.
187. Schou M. Normothymotics, "Mood-normalizers" - Are lithium and the imipramine drugs specific for affective disorders? Brit J Psychiat. 109:1963;803-809.
188. Schou M. Lithium in the treatment of other psychiatric and nonpsychiatric disorders. Arch Gen Psychiat. 36:1979;856-859.
189. Schou M. Lithium and electroconvulsive therapy. Adversaries, competitors, allies? Acta Psychiat Scand. 84:1991;435-438.
190. Scott M.E., Mullaly R.W. Lithium therapy for cocaine-induced psychosis. A clinical perspective Southern Med J. 74:1981;1475-1477.
191. Secunda S.K., Katz M.M., Swann A., Koslow S.H., Maas J.W., Chuang S., Croughan J. Mania diagnosis state measurement and prediction of treatment response. J Aff Dis. 8(2):1985;113-121.
192. Shapiro D.R., Quitkin F.M., Fleiss J.L. Response to maintenance therapy in bipolar illness. Arch Gen Psychiat. 46:1989;401-405.
193. Sharma V., Persad E. Pharmacotherapy of rapid cycling bipolar disorder. A review Lithium. 5:1994;117-125.
194. Sheard M.H., Marini J.L., Bridges C.I., Wagner E. The effect of lithium on impulsive aggressive behavior in man. Am J Psychiat. 133:1976;1409-1413.
195. Shopsin B., Kim S.S., Gershon S. A controlled study of lithium versus chlorpromazine in acute schizophrenics. Brit J Psychiat. 119:1971;435-440.
196. Shopsin B., Gershon S., Thompson H., Collins P. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiat. 32:1975;34-42.
197. Siassi I. Lithium treatment of impulsive behavior in children. J Clin Psychiat. 43:1982;482-484.
198. Singer H., Cheng R., Schou M. A controlled evaluation of lithium in the premenstrual tension syndrome. Brit J Psychiat. 124:1974;5-15.
199. Sletten I.W., Gershon S. The premenstrual syndrome. A discussion of its pathophysiology and treatment with lithium ion Comp Psychiat. 7:1966;197-206.
200. Small J.G., Small I.F., Milstein V., Kellams J.J., Klapper M.H. Manic symptoms. An indication for bilateral ECT Biolog Psychiat. 20:1985;125-134.
201. Small J.G., Klapper M.H., Kellams J.J., Miller M.J., Milstein V., Sharpley P.H., Small I.F. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiat. 45:1988;727-732.
202. Small J.G., Klapper M.H., Milstein V., Kellams J.J., Miller M.J., Marhenke J.D., Small T.F. Carbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiat. 48:1991;915-921.
203. Smulevitch A.B., Zavidovskaya G.I., Igonin A.L., Mikhailova N.M. The effectiveness of lithium in affective and schizoaffective psychosis. Brit J Psychiat. 125:1974;65-72.
204. Solomon D.A., Keitner G.I., Miller I.W., Shea M.T., Keller M.B. Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiat. 56:1995;5-13.
205. Spring G., Schweid D., Gray C., Steinberg J., Horwitz M. A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiat. 126:1970;1306-1310.
206. Stallone F., Shelley E., Mendlewicz J., Fieve R.R. The use of lithium in affective disorders. 3. A double-blind study of prophylaxis in bipolar illness. Am J Psychiat. 130:1973;1006-1010.
207. Stein G., Bernadt M. Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses. Brit J Psychiat. 162:1993;634-640.
208. Stoll A.L., Banov M., Kolbrener M., Mayer P.V., Tohen M., Strakowski S.M., Castillo J., Suppes T., Cohen B.M. Neurologic factors predict a favorable valproate response in bipolar schizoaffective disorder. J Clin Psychopharmacol. 14:1994;311-313.
209. Suppes T., Baldessarini R.J., Faedda G.L., Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiat. 48:1991;1082-1088.
210. Swann A.C., Secunda S.K., Katz M.M., Koslow S.H., Maas J.W., Chang S., Robins E. Lithium treatment of mania. Clinical characteristics, specificity of symptom change, and outcome Psychiat Res. 18:1986;127-141.
211. Takahashi R., Sakuma A., Itoh H., Kurihara M. Comparison of efficacy of lithium carbonate and chlorpromazine in mania. Report of collaborative study group on treatment of mania in Japan. Arch Gen Psychiat. 32:1975;1310-1318.
212. Thomas J., Reddy B. The treatment of mania. A retrospective evaluation of the effects of ECT, chlorpromazine, and lithium. J Aff Dis. 4:1982;85-92.
213. Tohen M., Waternaux C.M., Tsuang M.T., Hunt A.T. Four-year follow-up of twenty-four first-episode manic patients. J Aff Dis. 19:1990;79-86. a.
214. Tohen M., Waternaux C.M., Tsuang M.T. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiat. 47:1990;1106-1111. b.
215. Tupin J. Lithium use in nonmanic depressive conditions. Comp Psychiat. 13:1972;209-214.
216. Tyrer S.P., Walsh A., Edwards D.E., Berney T.P., Stephens D.A. Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Prog Neuro-Psychopharm Biol Psychiat. 8:1984;751-755.
217. 2+ response in neutrophils of manic-depressive patients. Effect of lithium therapy Neuropsychobiology. 27:1993;180-183.
218. van Woert M.H., Ambani L.M., Weintraub M.I. Manic behavior and levodopa. N Engl J Med. 285:1971;1326.
219. Vadnal R., Parthasarathy R. Myo-inositol monophosphatase. Diverse effects of lithium, carbamazepine, and valproate Neuropsychopharmacology. 12:1995;277-285.
220. Watanabe S., Ishino H., Otsuki S. Lithium and affective psychoses. Folia Psychiatrica et Neurologica Japonica. 28:1974;267-305.
221. Watanabe S., Ishino H., Otsuki S. Double-blind comparison of lithium carbonate and imipramine in treatment of depression. Arch Gen Psychiat. 32:1975;659-668.
222. Watkins S.E., Callender K., Thomas D.R., Tidmarsh S.F., Shaw D.M. The effect of carbamazepine and lithium on remission from affective illness. Brit J Psychiat. 150:1987;180-182.
223. Wehr T.A., Goodwin F.K. Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiat. 144:1987;1403-1411.
224. Will R.G., Young J.P., Thomas D.J. Kleine-Levin syndrome. Report of two cases with onset of symptoms precipitated by head trauma Brit J Psychiat. 152:1988;410-412.
225. Wilson K.C.M., Scott M., Abou-Saleh M., Burns R., Copeland J.R.M. Long-term effects of cognitive-behavioral therapy and lithium therapy on depression in the elderly. Brit J Psychiat. 167:1995;653-658.
226. Worrall E.P., Moody J.P., Peet M., Dick P., Smith A., Chambers C., Adams M., Naylor G.J. Controlled studies of the acute antidepressant effects of lithium. Brit J Psychiat. 135:1979;255-262.
227. Wren J.C., Kline N.S., Cooper T.B., Varga E., Canal O. Evaluation of lithium therapy in chronic alcoholism. Clin Med. 81:1974;33-36.
228. Young L.D., Taylor I., Holmstrom V. Lithium treatment of patients with affective illness associated with organic brain symptoms. Am J Psychiat. 134:1977;1405-1407.
229. Zemlan F.P., Hirschowitz J., Sautter F.J., Garver D.L. Impact of lithium therapy on core psychotic symptoms of schizophrenia. Brit J Psychiat. 144:1984;64-69. a.
230. Zemlan F.P., Hirschowitz J., Garver D.L. Mood-incongruent versus mood-congruent psychosis. Differential antipsychotic response to lithium therapy Psychiat Res. 11:1984;317-328. b.